vs
Ascendis Pharma A/S（ASND）与PREFORMED LINE PRODUCTS CO（PLPC）财务数据对比。点击上方公司名可切换其他公司
Ascendis Pharma A/S的季度营收约是PREFORMED LINE PRODUCTS CO的1.5倍（$267.3M vs $173.1M），Ascendis Pharma A/S同比增速更快（42.3% vs 3.6%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 10.8%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
预成型线路产品公司（PLPC）研发、生产和销售适用于输配电、通信及可再生能源基建领域的工程硬件组件，服务全球多地的公用事业、网络运营商及工业客户，提供可提升网络可靠性与运营效率的解决方案。
ASND vs PLPC — 直观对比
营收规模更大
ASND
是对方的1.5倍
$173.1M
营收增速更快
ASND
高出38.7%
3.6%
两年增速更快
ASND
近两年复合增速
10.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $173.1M |
| 净利润 | — | $8.4M |
| 毛利率 | 90.5% | 29.8% |
| 营业利润率 | — | 6.8% |
| 净利率 | — | 4.9% |
| 营收同比 | 42.3% | 3.6% |
| 净利润同比 | — | -19.3% |
| 每股收益（稀释后） | — | $1.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDPLPC
| Q4 25 | $267.3M | $173.1M | ||
| Q3 25 | $230.7M | $178.1M | ||
| Q2 25 | $170.7M | $169.6M | ||
| Q1 25 | $109.0M | $148.5M | ||
| Q4 24 | $187.8M | $167.1M | ||
| Q3 24 | $62.5M | $147.0M | ||
| Q2 24 | $38.9M | $138.7M | ||
| Q1 24 | $103.6M | $140.9M |
净利润ASNDPLPC
| Q4 25 | — | $8.4M | ||
| Q3 25 | $-65.9M | $2.6M | ||
| Q2 25 | $-42.0M | $12.7M | ||
| Q1 25 | $-102.2M | $11.5M | ||
| Q4 24 | — | $10.5M | ||
| Q3 24 | $-107.1M | $7.7M | ||
| Q2 24 | $-118.1M | $9.4M | ||
| Q1 24 | $-141.5M | $9.6M |
毛利率ASNDPLPC
| Q4 25 | 90.5% | 29.8% | ||
| Q3 25 | 89.5% | 29.7% | ||
| Q2 25 | 80.1% | 32.7% | ||
| Q1 25 | 82.6% | 32.8% | ||
| Q4 24 | 91.9% | 33.3% | ||
| Q3 24 | 80.6% | 31.1% | ||
| Q2 24 | 68.2% | 31.9% | ||
| Q1 24 | 92.1% | 31.3% |
营业利润率ASNDPLPC
| Q4 25 | — | 6.8% | ||
| Q3 25 | 5.1% | 7.4% | ||
| Q2 25 | -33.5% | 10.1% | ||
| Q1 25 | -103.2% | 8.8% | ||
| Q4 24 | — | 10.5% | ||
| Q3 24 | -167.3% | 7.1% | ||
| Q2 24 | -370.2% | 8.1% | ||
| Q1 24 | -51.2% | 8.2% |
净利率ASNDPLPC
| Q4 25 | — | 4.9% | ||
| Q3 25 | -28.5% | 1.5% | ||
| Q2 25 | -24.6% | 7.5% | ||
| Q1 25 | -93.7% | 7.8% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | -171.5% | 5.2% | ||
| Q2 24 | -303.9% | 6.8% | ||
| Q1 24 | -136.6% | 6.8% |
每股收益（稀释后）ASNDPLPC
| Q4 25 | — | $1.72 | ||
| Q3 25 | — | $0.53 | ||
| Q2 25 | — | $2.56 | ||
| Q1 25 | — | $2.33 | ||
| Q4 24 | — | $2.13 | ||
| Q3 24 | — | $1.54 | ||
| Q2 24 | — | $1.89 | ||
| Q1 24 | — | $1.94 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | — |
| 总债务越低越好 | — | $38.3M |
| 股东权益账面价值 | $-175.8M | $475.5M |
| 总资产 | $1.4B | $653.6M |
| 负债/权益比越低杠杆越低 | — | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资ASNDPLPC
| Q4 25 | $665.3M | — | ||
| Q3 25 | $582.2M | — | ||
| Q2 25 | $533.6M | — | ||
| Q1 25 | $559.4M | — | ||
| Q4 24 | $604.3M | — | ||
| Q3 24 | $675.6M | — | ||
| Q2 24 | $279.4M | — | ||
| Q1 24 | $345.9M | — |
总债务ASNDPLPC
| Q4 25 | — | $38.3M | ||
| Q3 25 | — | $36.0M | ||
| Q2 25 | — | $31.8M | ||
| Q1 25 | — | $29.1M | ||
| Q4 24 | — | $20.8M | ||
| Q3 24 | — | $27.2M | ||
| Q2 24 | — | $31.6M | ||
| Q1 24 | — | $55.0M |
股东权益ASNDPLPC
| Q4 25 | $-175.8M | $475.5M | ||
| Q3 25 | $-188.0M | $466.3M | ||
| Q2 25 | $-202.6M | $460.7M | ||
| Q1 25 | $-205.0M | $435.8M | ||
| Q4 24 | $-114.2M | $422.3M | ||
| Q3 24 | $-105.1M | $429.0M | ||
| Q2 24 | $-346.8M | $416.2M | ||
| Q1 24 | $-257.2M | $413.4M |
总资产ASNDPLPC
| Q4 25 | $1.4B | $653.6M | ||
| Q3 25 | $1.2B | $644.6M | ||
| Q2 25 | $1.2B | $631.5M | ||
| Q1 25 | $1.1B | $592.5M | ||
| Q4 24 | $1.3B | $573.9M | ||
| Q3 24 | $1.2B | $592.0M | ||
| Q2 24 | $819.0M | $572.6M | ||
| Q1 24 | $866.7M | $586.1M |
负债/权益比ASNDPLPC
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | $21.9M |
| 自由现金流经营现金流 - 资本支出 | — | $11.8M |
| 自由现金流率自由现金流/营收 | — | 6.8% |
| 资本支出强度资本支出/营收 | — | 5.9% |
| 现金转化率经营现金流/净利润 | — | 2.60× |
| 过去12个月自由现金流最近4个季度 | — | $33.3M |
8季度趋势，按日历期对齐
经营现金流ASNDPLPC
| Q4 25 | $58.2M | $21.9M | ||
| Q3 25 | — | $18.9M | ||
| Q2 25 | — | $26.9M | ||
| Q1 25 | $-15.5M | $5.7M | ||
| Q4 24 | $-330.7M | $24.1M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $28.3M | ||
| Q1 24 | $-109.7M | $5.8M |
自由现金流ASNDPLPC
| Q4 25 | — | $11.8M | ||
| Q3 25 | — | $8.3M | ||
| Q2 25 | — | $18.6M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $20.6M | ||
| Q3 24 | — | $5.8M | ||
| Q2 24 | — | $24.6M | ||
| Q1 24 | — | $1.8M |
自由现金流率ASNDPLPC
| Q4 25 | — | 6.8% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | -3.6% | ||
| Q4 24 | — | 12.3% | ||
| Q3 24 | — | 3.9% | ||
| Q2 24 | — | 17.7% | ||
| Q1 24 | — | 1.3% |
资本支出强度ASNDPLPC
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 6.0% | ||
| Q2 25 | — | 4.9% | ||
| Q1 25 | — | 7.4% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 2.8% |
现金转化率ASNDPLPC
| Q4 25 | — | 2.60× | ||
| Q3 25 | — | 7.21× | ||
| Q2 25 | — | 2.12× | ||
| Q1 25 | — | 0.49× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 1.22× | ||
| Q2 24 | — | 3.02× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
